Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise

Journal of the American College of Cardiology

Volumn 70, Issue 16, 2017, Pages 2022-2035

  Lavie, Carl J ^a   Pandey, Ambarish ^b   Lau, Dennis H ^c   Alpert, Martin A ^d   Sanders, Prashanthan ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d University of Missouri   (United States)

Author keywords

cardiac arrhythmia; cardiovascular diseases; fat; fitness; heart rhythm

Indexed keywords

ATRIAL FIBRILLATION; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; DISEASE SEVERITY; EXERCISE; HEART FUNCTION; HEMODYNAMICS; HUMAN; LEAN BODY WEIGHT; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; BODY COMPOSITION; PHYSIOLOGY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ATRIAL FIBRILLATION; BODY COMPOSITION; EXERCISE; HUMANS; OBESITY; PREVALENCE; PROGNOSIS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85031764424     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.09.002     Document Type: Review

References (111)

1. Flegal, K.M., Kruszon-Moran, D., Carroll, M.D., Fryar, C.D., Ogden, C.L., Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315 (2016), 2284–2291.
2. Lavie, C.J., De Schutter, A., Parto, P., et al. Obesity and prevalence of cardiovascular diseases and prognosis: the obesity paradox updated. Prog Cardiovasc Dis 58 (2016), 537–547.
3. Lavie, C.J., Sharma, A., Alpert, M.A., et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 58 (2016), 393–400.
4. Morin, D.P., Bernard, M.L., Madias, C., Rogers, P.A., Thihalolipavan, S., Estes, N.A. III, The state of the art: atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin Proc 91 (2016), 1778–1810.
5. Colilla, S., Crow, A., Petkun, W., Singer, D.E., Simon, T., Liu, X., Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 112 (2013), 1142–1147.
6. Sheikh, A., Patel, N.J., Nalluri, N., et al. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future. Prog Cardiovasc Dis 58 (2015), 105–116.
7. Menezes, A.R., Lavie, C.J., De Schutter, A., et al. Lifestyle modification in the prevention and treatment of atrial fibrillation. Prog Cardiovasc Dis 58 (2015), 117–125.
8. Lau, D.H., Middeldorp, M.E., Sanders, P., Obesity paradox in atrial fibrillation: a distracting reality or fictitious finding?. Eur Heart J 37 (2016), 2879–2881.
9. Nalliah, C.J., Sanders, P., Kottkamp, H., Kalman, J.M., The role of obesity in atrial fibrillation. Eur Heart J 37 (2015), 3–11.
10. Mahajan, R., Lau, D.H., Sanders, P., Impact of obesity on cardiac metabolism, fibrosis, and function. Trends Cardiovasc Med 25 (2015), 119–126.
11. Pathak, R.K., Mahajan, R., Lau, D.H., Sanders, P., The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol 31 (2015), 203–210.
12. Wang, T.J., Parise, H., Levy, D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004), 2471–2477.
13. Gami, A.S., Hodge, D.O., Herges, R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49 (2007), 565–571.
14. Tedrow, U.B., Conen, D., Ridker, P.M., et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women's Health Study). J Am Coll Cardiol 55 (2010), 2319–2327.
15. Knuiman, M., Briffa, T., Divitini, M., et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol 29 (2014), 181–190.
16. Huxley, R.R., Lopez, F.L., Folsom, A.R., et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123 (2011), 1501–1508.
17. Chatterjee, N.A., Giulianini, F., Geelhoed, B., et al. Genetic obesity and the risk of atrial fibrillation: casual estimates from Mendelian randomization. Circulation 135 (2017), 741–754.
18. Norby, F.L., Soliman, E.Z., Chen, L.Y., et al. Trajectories of cardiovascular risk factors and incidence of atrial fibrillation over a 25-year follow-up: the ARIC Study (Atherosclerosis Risk in Communities). Circulation 134 (2016), 599–610.
19. Wong, C.X., Sullivan, T., Sun, M.T., et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation. J Am Coll Cardiol EP 1 (2015), 139–152.
20. Tsang, T.S., Barnes, M.E., Miyasaka, Y., et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 29 (2008), 2227–2233.
21. Sandhu, R.K., Conen, D., Tedrow, U.B., et al. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J Am Heart Assoc, 3, 2014, e000916.
22. Alpert, M.A., Omran, J., Bostick, B., Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr Obes Rep 5 (2016), 424–434.
23. Alpert, M.A., Omran, J., Mehra, A., Ardhanari, S., Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 56 (2014), 391–400.
24. Alpert, M.A., Lavie, C.J., Agrawal, H., Aggarwal, K.B., Kumar, S.A., Obesity and heart failure: epidemiology, pathophysiology, clinical manifestation and management. Transl Res 164 (2014), 345–356.
25. Movahed, M.R., Saito, Y., Obesity is associated with left atrial enlargement. Exp Clin Cardiol 13 (2008), 89–91.
26. Kumar, P.V., Mundi, A., Caldito, G., Reddy, P.C., Higher body mass index is an independent predictor of left atrial enlargement. Int J Clin Med 2 (2011), 556–560.
27. Goudis, C.A., Korantzopoulos, P., Ntalas, I.V., Kallergis, E.M., Ketikoglou, D.C., Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links. J Cardiol 66 (2015), 361–369.
28. Abed, H.S., Wittert, G.A., Obesity and atrial fibrillation. Obes Rev 14 (2013), 929–938.
29. Abed, H.S., Samuel, C.S., Lau, D.H., et al. Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation. Heart Rhythm 10 (2013), 90–100.
30. Pathak, R., Lau, D.H., Mahajan, R., Sanders, P., Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Atr Fibrillation, 6, 2013, 986 eCollection.
31. Magnani, J.W., Hylek, E.M., Apovian, C.M., Obesity begins atrial fibrillation. A contemporary summary. Circulation 128 (2013), 401–405.
32. Munger, T.M., Dong, Y.X., Masaki, M., et al. Electrophysiological and hemodynamic, characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol 60 (2012), 851–860.
33. Pandit, S.V., Anumonwo, J., Jalife, J., Atrial fibrillation susceptibility in obesity. An excess adiposity and fibrosis complicity?. Circulation Res, 2016, 1468–1471.
34. Wanahita, N., Messerli, F.H., Bangalore, S., Gami, A.S., Somers, V.K., Steinberg, J.S., Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 155 (2008), 310–315.
35. Stritzke, J., Markus, M.R., Duderstadt, S., et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. J Am Coll Cardiol 54 (2009), 1982–1989.
36. Hatem, S.N., Redheuil, A., Grandjbakhch. Cardiac adipose tissue and atrial fibrillation. Cardiovasc Res 109 (2016), 502–509.
37. Al-Rawahi, M., Proletti, R., Thansoulis, G., Pericardial fat and atrial fibrillation: epidemiology, mechanisms and interventions. Int J Cardiol 195 (2015), 98–103.
38. Thanasoullis, G., Massaro, J.M., O'Donnel, C.J., Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Study. Circ Arrhythmia Electrophysiol 3 (2010), 345–350.
39. Wong, C.X., Abed, H., Molaee, P., et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 57 (2011), 1745–1751.
40. Wong, C.X., Sun, M.T., Odutayo, A., et al. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol, 9, 2016, e004378.
41. Lai, Y.H., Yun, C.H., Su, C.H., et al. Excessive interatrial adiposity is associated with left atrial remodeling, augmented contractile performance in asymptomatic population. Echo Res Pract 3 (2016), 5–15.
42. Mahajan, R., Lau, D.H., Brooks, A.G., et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 66 (2015), 1–11.
43. Venteclef, N., Guglielmi, V., Balse, E., et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J 36 (2015), 795–805a.
44. Haemers, P., Hamdi, H., Guedj, K., et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J 38 (2017), 53–61.
45. Rogers, P.A., Bernard, M.L., Madias, C., Thihalolipavan, S., Morin, D.P., Current evidence based understanding of the epidemiology, prevention, and treatment of atrial fibrillation. Curr Probl Cardiol, 2017 In press.
46. Nattel, S., Dobrev, D., Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol 13 (2016), 575–590.
47. Thanigaimani, S., McLennan, E., Linz, D., et al. Progression and reversibility of stretch induced atrial remodeling: characterization and clinical implications. Prog Biophys Mol Biol, 2017 Jul 19 [E-pub ahead of print].
48. Lee, S.H., Chen, Y.C., Chen, Y.J., et al. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 80 (2007), 1806–1815.
49. Iwasaki, Y.K., Shi, Y., Benito, B., et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm 9 (2012), 1409–1416.e1.
50. Fenger-Grøn, M., Overvad, K., Tjønneland, A., Frost, L., Lean body mass is the predominant anthropometric risk factor for atrial fibrillation. J Am Coll Cardiol 69 (2017), 2488–2497.
51. Nattel, S., Atrial fibrillation and body composition: is it fat or lean that ultimately determines the risk?. J Am Coll Cardiol 69 (2017), 2498–2501.
52. Guijian, L., Jinchuan, Y., Rongzeng, D., Jun, Q., Jun, W., Wenqing, Z., Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies. Pacing Clin Electrophysiol 36 (2013), 748–756.
53. Badheka, A.O., Rathod, A., Kizilbash, M.A., et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123 (2010), 646–651.
54. Sandhu, R.K., Ezekowitz, J., Andersson, U., et al. The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Eur Heart J 37 (2016), 2869–2878.
55. Pandey, A., Gersh, B.J., McGuire, D.K., et al. Association of body mass index with care and outcomes in patients with atrial fibrillation: results from the ORBIT-AF registry. J Am Coll Cardiol EP 2 (2016), 355–363.
56. Zhu, W., Wan, R., Liu, F., et al. Relation of body mass index with adverse outcomes among patients with atrial fibrillation: a meta-analysis and systematic review. J Am Heart Assoc, 5, 2016, e004006.
57. Pokorney, S.D., Piccini, J.P., Stevens, S.R., et al. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF. J Am Heart Assoc, 5, 2016, e002197.
58. Pandey, A., Kim, S., Moore, C., et al. Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation. J Am Coll Cardiol HF 5 (2017), 44–52.
59. Lavie, C.J., Cahalin, L.P., Chase, P., et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 88 (2013), 251–258.
60. Banack, H.R., Kaufman, J.S., The “obesity paradox” explained. Epidemiology 24 (2013), 461–462.
61. Lajous, M., Banack, H.R., Kaufman, J.S., Hernán, M.A., Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med 128 (2015), 334–336.
62. Banack, H.R., Kaufman, J.S., The obesity paradox: understanding the effect of obesity on morality among individuals with cardiovascular disease. Prev Med 62 (2014), 96–102.
63. Banack, H.R., Kaufman, J.S., Does selection bias explain the obesity paradox among individuals with cardiovascular disease?. Ann Epidemiol 25 (2015), 342–349.
64. Fukuchi, H., Nakashima, M., Araki, R., et al. Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis. J Clin Pharm Ther 34 (2009), 329–336.
65. Wallace, J.L., Reaves, A.B., Tolley, E.A., et al. Comparison of initial warfarin response in obese patients versus non-obese patients. J Thromb Thrombolysis 36 (2013), 96–101.
66. Buckley, L.F., Rybak, E., Aldemerdash, A., Cheng, J.W., Fanikos, J., Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age. Clin Cardiol 40 (2017), 46–52.
67. Glover, B.M., Walsh, S.J., McCann, C.J., et al. Biphasic energy selection for transthoracic cardioversion of atrial fibrillation: the BEST AF trial. Heart 94 (2008), 884–887.
68. Ardestani, A., Hoffman, H.J., Cooper, H.A., Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106 (2010), 369–373.
69. Letsas, K.P., Siklody, C.H., Korantzopoulos, P., et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol 164 (2013), 94–98.
70. Ector, J., Dragusin, O., Adriaenssens, B., et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol 50 (2007), 234–242.
71. Shoemaker, M.B., Muhammad, R., Farrell, M., et al. Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am J Cardiol 111 (2013), 368–373.
72. Abed, H., Wittert, G.A., Leong, D.P., et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation. JAMA 310 (2013), 2050–2060.
73. Pathak, R.K., Middeldorp, M.E., Meredith, M., et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 65 (2015), 2159–2169.
74. Biancari, F., Mahar, M.A., Meta-analysis of randomized trials on the efficacy of posterior pericardiectomy in preventing atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg 139 (2010), 158–161.
75. Pokushalov, E., Kozlov, B., Romanov, A., et al. Botulinum toxin in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 64 (2014), 628–629.
76. Huxley, R.R., Misialek, J.R., Agarwal, S.K., et al. Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study. Circ Arrhythm Electrophysiol 7 (2014), 620–625.
77. Jamaly, S., Carlsson, L., Peltonen, M., Jacobson, P., Sjostrom, L., Karason, K., Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol 68 (2016), 2497–2504.
78. Alonso, A., Bahnson, J.L., Gaussoin, S.A., et al. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial. Am Heart J 170 (2015), 770–777.e5.
79. Fioravanti, F., Brisinda, D., Sorbo, A.R., Fenici, R., BMI reduction decreases AF recurrence rate in a Mediterranean cohort. J Am Coll Cardiol 66 (2015), 2264–2265.
80. Pathak, R.K., Middeldorp, M.E., Lau, D.H., et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol 64 (2014), 2222–2231.
81. Abed, H.S., Nelson, A.J., Richardson, J.D., et al. Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation. Am Heart J 169 (2015), 655–662.e2.
82. Wong, C.X., Ganesan, A.N., Selvanayagam, J.B., Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J 38 (2017), 1294–1302.
83. Berry, J.D., Pandey, A., Gao, A., et al. Physical fitness and risk for heart failure and coronary artery disease. Circ Heart Fail 6 (2013), 627–634.
84. Pandey, A., Garg, S., Khunger, M., et al. Dose-response relationship between physical activity and risk of heart failure: a meta-analysis. Circulation 132 (2015), 1786–1794.
85. Pandey, A., Patel, M., Gao, A., et al. Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study. Am Heart J 169 (2015), 290–297.e1.
86. Sattelmair, J., Pertman, J., Ding, E.L., Kohl, H.W. 3rd, Haskell, W., Lee, I.M., Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 124 (2011), 789–795.
87. Pandey, A., LaMonte, M., Klein, L., et al. Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol 69 (2017), 1129–1142.
88. Andersen, K., Farahmand, B., Ahlbom, A., et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J 34 (2013), 3624–3631.
89. Molina, L., Mont, L., Marrugat, J., et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace 10 (2008), 618–623.
90. Myrstad, M., Lochen, M.L., Graff-Iversen, S., et al. Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice. Scand J Med Sci Sports 24 (2014), e238–e244.
91. Grimsmo, J., Grundvold, I., Maehlum, S., Arnesen, H., High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors–a 28-30 years follow-up study. Eur J Cardiovasc Prev Rehabil 17 (2010), 100–105.
92. Aizer, A., Gaziano, J.M., Cook, N.R., Manson, J.E., Buring, J.E., Albert, C.M., Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol 103 (2009), 1572–1577.
93. Azarbal, F., Stefanick, M.L., Salmoirago-Blotcher, E., et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc, 3, 2014, e001127.
94. Drca, N., Wolk, A., Jensen-Urstad, M., Larsson, S.C., Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart 100 (2014), 1037–1042.
95. Drca, N., Wolk, A., Jensen-Urstad, M., Larsson, S.C., Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart 101 (2015), 1627–1630.
96. Morseth, B., Graff-Iversen, S., Jacobsen, B.K., et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromso Study. Eur Heart J 37 (2016), 2307–2313.
97. Mozaffarian, D., Furberg, C.D., Psaty, B.M., Siscovick, D., Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation 118 (2008), 800–807.
98. Kwok, C.S., Anderson, S.G., Myint, P.K., Mamas, M.A., Loke, Y.K., Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol 177 (2014), 467–476.
99. Elliott, A.D., Maatman, B., Emery, M.S., Sanders, P., The role of exercise in atrial fibrillation prevention and promotion: finding optimal ranges for health. Heart Rhythm, 2017 Jul 8 [E-pub ahead of print].
100. Faselis, C., Kokkinos, P., Tsimploulis, A., et al. Exercise capacity and atrial fibrillation risk in veterans: a cohort study. Mayo Clin Proc 91 (2016), 558–566.
101. Khan, H., Kella, D., Rauramaa, R., Savonen, K., Lloyd, M.S., Laukkanen, J.A., Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study. Heart Rhythm 12 (2015), 1424–1430.
102. Qureshi, W.T., Alirhayim, Z., Blaha, M.J., et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) Project. Circulation 131 (2015), 1827–1834.
103. Pathak, R.K., Elliott, A., Middeldorp, M.E., et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol 66 (2015), 985–996.
104. Malmo, V., Nes, B.M., Amundsen, B.H., et al. Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial. Circulation 133 (2016), 466–473.
105. Pandey, A., Allen, N., Ayers, C., et al. Fitness in young adulthood and long-term cardiac structure and function: the CARDIA study. J Am Coll Cardiol HF 5 (2017), 347–355.
106. Brinker, S.K., Pandey, A., Ayers, C.R., et al. Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal Study. J Am Coll Cardiol HF 2 (2014), 238–246.
107. Pandey, A., Darden, D., Berry, J.D., Low fitness in midlife: a novel therapeutic target for heart failure with preserved ejection fraction prevention. Prog Cardiovasc Dis 58 (2015), 87–93.
108. Pandey, A., Parashar, A., Kumbhani, D.J., et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail 8 (2015), 33–40.
109. O'Connor, C.M., Whellan, D.J., Lee, K.L., et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301 (2009), 1439–1450.
110. Working Group on Cardiac Rehabilitation & Exercise Physiology, Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise training in chronic heart failure patients. Eur Heart J 22 (2001), 125–135.
111. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.